nodes	percent_of_prediction	percent_of_DWPC	metapath
Sirolimus—CYP3A4—Esomeprazole—Barrett's esophagus	0.144	0.389	CbGbCtD
Sirolimus—ABCB1—Omeprazole—Barrett's esophagus	0.142	0.382	CbGbCtD
Sirolimus—CYP3A4—Omeprazole—Barrett's esophagus	0.0851	0.229	CbGbCtD
Sirolimus—EIF4E—digestive system—Barrett's esophagus	0.0101	0.183	CbGeAlD
Sirolimus—FGF2—smooth muscle tissue—Barrett's esophagus	0.0078	0.142	CbGeAlD
Sirolimus—MTOR—epithelium—Barrett's esophagus	0.00514	0.0933	CbGeAlD
Sirolimus—EIF4E—Signaling mediated by p38-alpha and p38-beta—SLC9A1—Barrett's esophagus	0.00507	0.0528	CbGpPWpGaD
Sirolimus—MTOR—smooth muscle tissue—Barrett's esophagus	0.00495	0.0899	CbGeAlD
Sirolimus—FKBP1A—epithelium—Barrett's esophagus	0.00462	0.0839	CbGeAlD
Sirolimus—FKBP1A—smooth muscle tissue—Barrett's esophagus	0.00445	0.0809	CbGeAlD
Sirolimus—SLCO1B1—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.00445	0.0463	CbGpPWpGaD
Sirolimus—MTOR—digestive system—Barrett's esophagus	0.00391	0.071	CbGeAlD
Sirolimus—FKBP1A—digestive system—Barrett's esophagus	0.00352	0.0638	CbGeAlD
Sirolimus—EIF4E—BDNF signaling pathway—CRTC1—Barrett's esophagus	0.00327	0.0341	CbGpPWpGaD
Sirolimus—SLC47A1—digestive system—Barrett's esophagus	0.00302	0.0549	CbGeAlD
Sirolimus—SLCO1B1—digestive system—Barrett's esophagus	0.00298	0.0542	CbGeAlD
Sirolimus—FKBP1A—TGF-beta Receptor Signaling—BMP4—Barrett's esophagus	0.00276	0.0288	CbGpPWpGaD
Sirolimus—FGF2—Differentiation Pathway—BMP4—Barrett's esophagus	0.0023	0.024	CbGpPWpGaD
Sirolimus—Creatinine increased—Esomeprazole—Barrett's esophagus	0.00226	0.00473	CcSEcCtD
Sirolimus—Creatinine increased—Omeprazole—Barrett's esophagus	0.00226	0.00473	CcSEcCtD
Sirolimus—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.00223	0.0232	CbGpPWpGaD
Sirolimus—Blood uric acid increased—Omeprazole—Barrett's esophagus	0.00219	0.00459	CcSEcCtD
Sirolimus—Blood uric acid increased—Esomeprazole—Barrett's esophagus	0.00219	0.00459	CcSEcCtD
Sirolimus—Phosphatase alkaline increased—Omeprazole—Barrett's esophagus	0.00215	0.00451	CcSEcCtD
Sirolimus—Hepatocellular injury—Esomeprazole—Barrett's esophagus	0.00215	0.00451	CcSEcCtD
Sirolimus—Hiccups—Esomeprazole—Barrett's esophagus	0.00215	0.00451	CcSEcCtD
Sirolimus—Phosphatase alkaline increased—Esomeprazole—Barrett's esophagus	0.00215	0.00451	CcSEcCtD
Sirolimus—Hiccups—Omeprazole—Barrett's esophagus	0.00215	0.00451	CcSEcCtD
Sirolimus—Hepatocellular injury—Omeprazole—Barrett's esophagus	0.00215	0.00451	CcSEcCtD
Sirolimus—FGF2—Cardiac Progenitor Differentiation—BMP4—Barrett's esophagus	0.00213	0.0221	CbGpPWpGaD
Sirolimus—Eructation—Esomeprazole—Barrett's esophagus	0.00211	0.00443	CcSEcCtD
Sirolimus—Eructation—Omeprazole—Barrett's esophagus	0.00211	0.00443	CcSEcCtD
Sirolimus—Candida infection—Omeprazole—Barrett's esophagus	0.00205	0.0043	CcSEcCtD
Sirolimus—Candida infection—Esomeprazole—Barrett's esophagus	0.00205	0.0043	CcSEcCtD
Sirolimus—Fluid retention—Esomeprazole—Barrett's esophagus	0.00204	0.00428	CcSEcCtD
Sirolimus—Fluid retention—Omeprazole—Barrett's esophagus	0.00204	0.00428	CcSEcCtD
Sirolimus—Oesophagitis—Omeprazole—Barrett's esophagus	0.00197	0.00412	CcSEcCtD
Sirolimus—Oesophagitis—Esomeprazole—Barrett's esophagus	0.00197	0.00412	CcSEcCtD
Sirolimus—FGF2—Mecp2 and Associated Rett Syndrome—SST—Barrett's esophagus	0.00196	0.0204	CbGpPWpGaD
Sirolimus—Urine output increased—Esomeprazole—Barrett's esophagus	0.00194	0.00407	CcSEcCtD
Sirolimus—Bladder pain—Omeprazole—Barrett's esophagus	0.00194	0.00407	CcSEcCtD
Sirolimus—Neoplasm—Esomeprazole—Barrett's esophagus	0.00194	0.00407	CcSEcCtD
Sirolimus—Mouth ulceration—Esomeprazole—Barrett's esophagus	0.00194	0.00407	CcSEcCtD
Sirolimus—Urine output increased—Omeprazole—Barrett's esophagus	0.00194	0.00407	CcSEcCtD
Sirolimus—Neoplasm—Omeprazole—Barrett's esophagus	0.00194	0.00407	CcSEcCtD
Sirolimus—Mouth ulceration—Omeprazole—Barrett's esophagus	0.00194	0.00407	CcSEcCtD
Sirolimus—Bladder pain—Esomeprazole—Barrett's esophagus	0.00194	0.00407	CcSEcCtD
Sirolimus—Hypertonia—Omeprazole—Barrett's esophagus	0.00189	0.00395	CcSEcCtD
Sirolimus—Hypertonia—Esomeprazole—Barrett's esophagus	0.00189	0.00395	CcSEcCtD
Sirolimus—Abnormal vision—Omeprazole—Barrett's esophagus	0.00188	0.00393	CcSEcCtD
Sirolimus—Abnormal vision—Esomeprazole—Barrett's esophagus	0.00188	0.00393	CcSEcCtD
Sirolimus—Lymphadenopathy—Omeprazole—Barrett's esophagus	0.00183	0.00383	CcSEcCtD
Sirolimus—Lymphadenopathy—Esomeprazole—Barrett's esophagus	0.00183	0.00383	CcSEcCtD
Sirolimus—Ear pain—Omeprazole—Barrett's esophagus	0.00183	0.00383	CcSEcCtD
Sirolimus—Ear pain—Esomeprazole—Barrett's esophagus	0.00183	0.00383	CcSEcCtD
Sirolimus—EIF4E—Signaling mediated by p38-alpha and p38-beta—PTGS2—Barrett's esophagus	0.00182	0.019	CbGpPWpGaD
Sirolimus—Blood alkaline phosphatase increased—Omeprazole—Barrett's esophagus	0.0018	0.00376	CcSEcCtD
Sirolimus—Blood alkaline phosphatase increased—Esomeprazole—Barrett's esophagus	0.0018	0.00376	CcSEcCtD
Sirolimus—Polyuria—Omeprazole—Barrett's esophagus	0.00178	0.00373	CcSEcCtD
Sirolimus—Polyuria—Esomeprazole—Barrett's esophagus	0.00178	0.00373	CcSEcCtD
Sirolimus—SLCO1B1—Irinotecan Pathway—APC—Barrett's esophagus	0.00177	0.0184	CbGpPWpGaD
Sirolimus—Gastroenteritis—Omeprazole—Barrett's esophagus	0.00176	0.00369	CcSEcCtD
Sirolimus—Gastroenteritis—Esomeprazole—Barrett's esophagus	0.00176	0.00369	CcSEcCtD
Sirolimus—Hepatic failure—Omeprazole—Barrett's esophagus	0.00174	0.00364	CcSEcCtD
Sirolimus—Hepatic failure—Esomeprazole—Barrett's esophagus	0.00174	0.00364	CcSEcCtD
Sirolimus—Injury—Esomeprazole—Barrett's esophagus	0.0017	0.00356	CcSEcCtD
Sirolimus—Injury—Omeprazole—Barrett's esophagus	0.0017	0.00356	CcSEcCtD
Sirolimus—EIF4E—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HGF—Barrett's esophagus	0.00167	0.0174	CbGpPWpGaD
Sirolimus—Increased appetite—Omeprazole—Barrett's esophagus	0.00166	0.00348	CcSEcCtD
Sirolimus—Increased appetite—Esomeprazole—Barrett's esophagus	0.00166	0.00348	CcSEcCtD
Sirolimus—Renal impairment—Omeprazole—Barrett's esophagus	0.00164	0.00344	CcSEcCtD
Sirolimus—Renal impairment—Esomeprazole—Barrett's esophagus	0.00164	0.00344	CcSEcCtD
Sirolimus—Hypoglycaemia—Omeprazole—Barrett's esophagus	0.0016	0.00335	CcSEcCtD
Sirolimus—Hypoglycaemia—Esomeprazole—Barrett's esophagus	0.0016	0.00335	CcSEcCtD
Sirolimus—Hyponatraemia—Omeprazole—Barrett's esophagus	0.00157	0.00328	CcSEcCtD
Sirolimus—Hyponatraemia—Esomeprazole—Barrett's esophagus	0.00157	0.00328	CcSEcCtD
Sirolimus—Osteoarthritis—Esomeprazole—Barrett's esophagus	0.00156	0.00327	CcSEcCtD
Sirolimus—Osteoarthritis—Omeprazole—Barrett's esophagus	0.00156	0.00327	CcSEcCtD
Sirolimus—FKBP1A—Calcium signaling in the CD4+ TCR pathway—PTGS2—Barrett's esophagus	0.00155	0.0162	CbGpPWpGaD
Sirolimus—CYP3A5—digestive system—Barrett's esophagus	0.00153	0.0278	CbGeAlD
Sirolimus—Face oedema—Esomeprazole—Barrett's esophagus	0.00151	0.00316	CcSEcCtD
Sirolimus—Face oedema—Omeprazole—Barrett's esophagus	0.00151	0.00316	CcSEcCtD
Sirolimus—MTOR—Extracellular vesicle-mediated signaling in recipient cells—HGF—Barrett's esophagus	0.00151	0.0157	CbGpPWpGaD
Sirolimus—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00149	0.0155	CbGpPWpGaD
Sirolimus—EIF4E—Structural Pathway of Interleukin 1 (IL-1)—RELA—Barrett's esophagus	0.00148	0.0154	CbGpPWpGaD
Sirolimus—CYP3A7—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.00147	0.0153	CbGpPWpGaD
Sirolimus—Blood creatinine increased—Esomeprazole—Barrett's esophagus	0.00146	0.00306	CcSEcCtD
Sirolimus—Blood creatinine increased—Omeprazole—Barrett's esophagus	0.00146	0.00306	CcSEcCtD
Sirolimus—Hypokalaemia—Omeprazole—Barrett's esophagus	0.00142	0.00298	CcSEcCtD
Sirolimus—Hypokalaemia—Esomeprazole—Barrett's esophagus	0.00142	0.00298	CcSEcCtD
Sirolimus—Breast disorder—Omeprazole—Barrett's esophagus	0.00141	0.00296	CcSEcCtD
Sirolimus—Breast disorder—Esomeprazole—Barrett's esophagus	0.00141	0.00296	CcSEcCtD
Sirolimus—Aspartate aminotransferase increased—Omeprazole—Barrett's esophagus	0.00141	0.00295	CcSEcCtD
Sirolimus—Aspartate aminotransferase increased—Esomeprazole—Barrett's esophagus	0.00141	0.00295	CcSEcCtD
Sirolimus—FGF2—Differentiation Pathway—HGF—Barrett's esophagus	0.00139	0.0145	CbGpPWpGaD
Sirolimus—Gastritis—Esomeprazole—Barrett's esophagus	0.00138	0.0029	CcSEcCtD
Sirolimus—Gastritis—Omeprazole—Barrett's esophagus	0.00138	0.0029	CcSEcCtD
Sirolimus—Alanine aminotransferase increased—Omeprazole—Barrett's esophagus	0.00138	0.00289	CcSEcCtD
Sirolimus—Alanine aminotransferase increased—Esomeprazole—Barrett's esophagus	0.00138	0.00289	CcSEcCtD
Sirolimus—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.00137	0.0143	CbGpPWpGaD
Sirolimus—Abdominal distension—Esomeprazole—Barrett's esophagus	0.00136	0.00285	CcSEcCtD
Sirolimus—Abdominal distension—Omeprazole—Barrett's esophagus	0.00136	0.00285	CcSEcCtD
Sirolimus—MTOR—BDNF signaling pathway—CRTC1—Barrett's esophagus	0.00135	0.0141	CbGpPWpGaD
Sirolimus—Asthma—Esomeprazole—Barrett's esophagus	0.00135	0.00283	CcSEcCtD
Sirolimus—Influenza—Esomeprazole—Barrett's esophagus	0.00135	0.00283	CcSEcCtD
Sirolimus—Dysphagia—Esomeprazole—Barrett's esophagus	0.00135	0.00283	CcSEcCtD
Sirolimus—Influenza—Omeprazole—Barrett's esophagus	0.00135	0.00283	CcSEcCtD
Sirolimus—Asthma—Omeprazole—Barrett's esophagus	0.00135	0.00283	CcSEcCtD
Sirolimus—Dysphagia—Omeprazole—Barrett's esophagus	0.00135	0.00283	CcSEcCtD
Sirolimus—Pancreatitis—Esomeprazole—Barrett's esophagus	0.00132	0.00277	CcSEcCtD
Sirolimus—Pancreatitis—Omeprazole—Barrett's esophagus	0.00132	0.00277	CcSEcCtD
Sirolimus—Pancytopenia—Omeprazole—Barrett's esophagus	0.00128	0.00269	CcSEcCtD
Sirolimus—Pancytopenia—Esomeprazole—Barrett's esophagus	0.00128	0.00269	CcSEcCtD
Sirolimus—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.00128	0.0133	CbGpPWpGaD
Sirolimus—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.00128	0.0133	CbGpPWpGaD
Sirolimus—FGF2—Neural Crest Differentiation—BMP4—Barrett's esophagus	0.00127	0.0132	CbGpPWpGaD
Sirolimus—Neutropenia—Omeprazole—Barrett's esophagus	0.00126	0.00264	CcSEcCtD
Sirolimus—Neutropenia—Esomeprazole—Barrett's esophagus	0.00126	0.00264	CcSEcCtD
Sirolimus—Dysuria—Esomeprazole—Barrett's esophagus	0.00126	0.00264	CcSEcCtD
Sirolimus—Dysuria—Omeprazole—Barrett's esophagus	0.00126	0.00264	CcSEcCtD
Sirolimus—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.00125	0.00263	CcSEcCtD
Sirolimus—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.00125	0.00263	CcSEcCtD
Sirolimus—Pollakiuria—Esomeprazole—Barrett's esophagus	0.00125	0.00261	CcSEcCtD
Sirolimus—Pollakiuria—Omeprazole—Barrett's esophagus	0.00125	0.00261	CcSEcCtD
Sirolimus—Erectile dysfunction—Omeprazole—Barrett's esophagus	0.00124	0.0026	CcSEcCtD
Sirolimus—Erectile dysfunction—Esomeprazole—Barrett's esophagus	0.00124	0.0026	CcSEcCtD
Sirolimus—EIF4E—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—APC—Barrett's esophagus	0.00124	0.0129	CbGpPWpGaD
Sirolimus—Weight increased—Esomeprazole—Barrett's esophagus	0.00123	0.00257	CcSEcCtD
Sirolimus—Weight increased—Omeprazole—Barrett's esophagus	0.00123	0.00257	CcSEcCtD
Sirolimus—Weight decreased—Omeprazole—Barrett's esophagus	0.00122	0.00256	CcSEcCtD
Sirolimus—Weight decreased—Esomeprazole—Barrett's esophagus	0.00122	0.00256	CcSEcCtD
Sirolimus—CYP3A7—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.00121	0.0126	CbGpPWpGaD
Sirolimus—Infestation NOS—Esomeprazole—Barrett's esophagus	0.0012	0.00252	CcSEcCtD
Sirolimus—Infestation—Esomeprazole—Barrett's esophagus	0.0012	0.00252	CcSEcCtD
Sirolimus—Infestation NOS—Omeprazole—Barrett's esophagus	0.0012	0.00252	CcSEcCtD
Sirolimus—Infestation—Omeprazole—Barrett's esophagus	0.0012	0.00252	CcSEcCtD
Sirolimus—CYP3A5—Irinotecan Pathway—APC—Barrett's esophagus	0.00117	0.0122	CbGpPWpGaD
Sirolimus—Stomatitis—Omeprazole—Barrett's esophagus	0.00117	0.00246	CcSEcCtD
Sirolimus—Stomatitis—Esomeprazole—Barrett's esophagus	0.00117	0.00246	CcSEcCtD
Sirolimus—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.00117	0.00245	CcSEcCtD
Sirolimus—Conjunctivitis—Omeprazole—Barrett's esophagus	0.00117	0.00245	CcSEcCtD
Sirolimus—Urinary tract infection—Omeprazole—Barrett's esophagus	0.00117	0.00245	CcSEcCtD
Sirolimus—Conjunctivitis—Esomeprazole—Barrett's esophagus	0.00117	0.00245	CcSEcCtD
Sirolimus—CYP3A4—digestive system—Barrett's esophagus	0.00115	0.0209	CbGeAlD
Sirolimus—Haematuria—Esomeprazole—Barrett's esophagus	0.00115	0.0024	CcSEcCtD
Sirolimus—Haematuria—Omeprazole—Barrett's esophagus	0.00115	0.0024	CcSEcCtD
Sirolimus—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.00114	0.00238	CcSEcCtD
Sirolimus—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.00114	0.00238	CcSEcCtD
Sirolimus—Epistaxis—Omeprazole—Barrett's esophagus	0.00114	0.00238	CcSEcCtD
Sirolimus—Epistaxis—Esomeprazole—Barrett's esophagus	0.00114	0.00238	CcSEcCtD
Sirolimus—Sinusitis—Omeprazole—Barrett's esophagus	0.00113	0.00237	CcSEcCtD
Sirolimus—Sinusitis—Esomeprazole—Barrett's esophagus	0.00113	0.00237	CcSEcCtD
Sirolimus—MTOR—Extracellular vesicle-mediated signaling in recipient cells—APC—Barrett's esophagus	0.00112	0.0116	CbGpPWpGaD
Sirolimus—EIF4E—Signaling mediated by p38-alpha and p38-beta—TP53—Barrett's esophagus	0.00108	0.0113	CbGpPWpGaD
Sirolimus—Rhinitis—Omeprazole—Barrett's esophagus	0.00108	0.00227	CcSEcCtD
Sirolimus—Rhinitis—Esomeprazole—Barrett's esophagus	0.00108	0.00227	CcSEcCtD
Sirolimus—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00108	0.0112	CbGpPWpGaD
Sirolimus—Hallucination—Esomeprazole—Barrett's esophagus	0.00107	0.00225	CcSEcCtD
Sirolimus—Hypoaesthesia—Omeprazole—Barrett's esophagus	0.00107	0.00225	CcSEcCtD
Sirolimus—Hypoaesthesia—Esomeprazole—Barrett's esophagus	0.00107	0.00225	CcSEcCtD
Sirolimus—Hallucination—Omeprazole—Barrett's esophagus	0.00107	0.00225	CcSEcCtD
Sirolimus—Pharyngitis—Omeprazole—Barrett's esophagus	0.00107	0.00225	CcSEcCtD
Sirolimus—Pharyngitis—Esomeprazole—Barrett's esophagus	0.00107	0.00225	CcSEcCtD
Sirolimus—ABCB1—epithelium—Barrett's esophagus	0.00107	0.0194	CbGeAlD
Sirolimus—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.00107	0.00223	CcSEcCtD
Sirolimus—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.00107	0.00223	CcSEcCtD
Sirolimus—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.00106	0.00223	CcSEcCtD
Sirolimus—Oedema peripheral—Omeprazole—Barrett's esophagus	0.00106	0.00223	CcSEcCtD
Sirolimus—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.00106	0.00222	CcSEcCtD
Sirolimus—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.00106	0.00222	CcSEcCtD
Sirolimus—CYP3A5—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.00106	0.011	CbGpPWpGaD
Sirolimus—Urethral disorder—Esomeprazole—Barrett's esophagus	0.00106	0.00222	CcSEcCtD
Sirolimus—Urethral disorder—Omeprazole—Barrett's esophagus	0.00106	0.00222	CcSEcCtD
Sirolimus—Visual impairment—Esomeprazole—Barrett's esophagus	0.00104	0.00218	CcSEcCtD
Sirolimus—Visual impairment—Omeprazole—Barrett's esophagus	0.00104	0.00218	CcSEcCtD
Sirolimus—EIF4E—Leptin signaling pathway—RELA—Barrett's esophagus	0.00102	0.0106	CbGpPWpGaD
Sirolimus—SLC47A1—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	0.00101	0.0105	CbGpPWpGaD
Sirolimus—Tinnitus—Omeprazole—Barrett's esophagus	0.00101	0.00211	CcSEcCtD
Sirolimus—Tinnitus—Esomeprazole—Barrett's esophagus	0.00101	0.00211	CcSEcCtD
Sirolimus—Immune system disorder—Esomeprazole—Barrett's esophagus	0.000976	0.00204	CcSEcCtD
Sirolimus—Immune system disorder—Omeprazole—Barrett's esophagus	0.000976	0.00204	CcSEcCtD
Sirolimus—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.000974	0.00204	CcSEcCtD
Sirolimus—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.000974	0.00204	CcSEcCtD
Sirolimus—Chills—Esomeprazole—Barrett's esophagus	0.000969	0.00203	CcSEcCtD
Sirolimus—Chills—Omeprazole—Barrett's esophagus	0.000969	0.00203	CcSEcCtD
Sirolimus—Malnutrition—Omeprazole—Barrett's esophagus	0.00094	0.00197	CcSEcCtD
Sirolimus—Malnutrition—Esomeprazole—Barrett's esophagus	0.00094	0.00197	CcSEcCtD
Sirolimus—Flatulence—Esomeprazole—Barrett's esophagus	0.000927	0.00194	CcSEcCtD
Sirolimus—Flatulence—Omeprazole—Barrett's esophagus	0.000927	0.00194	CcSEcCtD
Sirolimus—Tension—Esomeprazole—Barrett's esophagus	0.000923	0.00193	CcSEcCtD
Sirolimus—Tension—Omeprazole—Barrett's esophagus	0.000923	0.00193	CcSEcCtD
Sirolimus—Nervousness—Omeprazole—Barrett's esophagus	0.000913	0.00191	CcSEcCtD
Sirolimus—Nervousness—Esomeprazole—Barrett's esophagus	0.000913	0.00191	CcSEcCtD
Sirolimus—Back pain—Esomeprazole—Barrett's esophagus	0.00091	0.00191	CcSEcCtD
Sirolimus—Back pain—Omeprazole—Barrett's esophagus	0.00091	0.00191	CcSEcCtD
Sirolimus—Muscle spasms—Omeprazole—Barrett's esophagus	0.000904	0.00189	CcSEcCtD
Sirolimus—Muscle spasms—Esomeprazole—Barrett's esophagus	0.000904	0.00189	CcSEcCtD
Sirolimus—FGF2—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.000884	0.00921	CbGpPWpGaD
Sirolimus—Tremor—Esomeprazole—Barrett's esophagus	0.000881	0.00185	CcSEcCtD
Sirolimus—Tremor—Omeprazole—Barrett's esophagus	0.000881	0.00185	CcSEcCtD
Sirolimus—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.000873	0.00183	CcSEcCtD
Sirolimus—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.000873	0.00183	CcSEcCtD
Sirolimus—CYP3A5—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000872	0.00908	CbGpPWpGaD
Sirolimus—Anaemia—Esomeprazole—Barrett's esophagus	0.000869	0.00182	CcSEcCtD
Sirolimus—Anaemia—Omeprazole—Barrett's esophagus	0.000869	0.00182	CcSEcCtD
Sirolimus—MTOR—ErbB1 downstream signaling—SLC9A1—Barrett's esophagus	0.000868	0.00904	CbGpPWpGaD
Sirolimus—Agitation—Esomeprazole—Barrett's esophagus	0.000864	0.00181	CcSEcCtD
Sirolimus—Agitation—Omeprazole—Barrett's esophagus	0.000864	0.00181	CcSEcCtD
Sirolimus—Angioedema—Esomeprazole—Barrett's esophagus	0.000859	0.0018	CcSEcCtD
Sirolimus—Angioedema—Omeprazole—Barrett's esophagus	0.000859	0.0018	CcSEcCtD
Sirolimus—Malaise—Omeprazole—Barrett's esophagus	0.000848	0.00178	CcSEcCtD
Sirolimus—Malaise—Esomeprazole—Barrett's esophagus	0.000848	0.00178	CcSEcCtD
Sirolimus—Leukopenia—Esomeprazole—Barrett's esophagus	0.000842	0.00176	CcSEcCtD
Sirolimus—Leukopenia—Omeprazole—Barrett's esophagus	0.000842	0.00176	CcSEcCtD
Sirolimus—SLC47A1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000838	0.00872	CbGpPWpGaD
Sirolimus—Palpitations—Esomeprazole—Barrett's esophagus	0.000831	0.00174	CcSEcCtD
Sirolimus—Palpitations—Omeprazole—Barrett's esophagus	0.000831	0.00174	CcSEcCtD
Sirolimus—ABCB1—HIF-1-alpha transcription factor network—MCL1—Barrett's esophagus	0.000822	0.00856	CbGpPWpGaD
Sirolimus—Cough—Omeprazole—Barrett's esophagus	0.000821	0.00172	CcSEcCtD
Sirolimus—Cough—Esomeprazole—Barrett's esophagus	0.000821	0.00172	CcSEcCtD
Sirolimus—ABCB1—digestive system—Barrett's esophagus	0.000813	0.0148	CbGeAlD
Sirolimus—Hypertension—Esomeprazole—Barrett's esophagus	0.000812	0.0017	CcSEcCtD
Sirolimus—Hypertension—Omeprazole—Barrett's esophagus	0.000812	0.0017	CcSEcCtD
Sirolimus—Chest pain—Omeprazole—Barrett's esophagus	0.000801	0.00168	CcSEcCtD
Sirolimus—Myalgia—Omeprazole—Barrett's esophagus	0.000801	0.00168	CcSEcCtD
Sirolimus—Arthralgia—Esomeprazole—Barrett's esophagus	0.000801	0.00168	CcSEcCtD
Sirolimus—Chest pain—Esomeprazole—Barrett's esophagus	0.000801	0.00168	CcSEcCtD
Sirolimus—Myalgia—Esomeprazole—Barrett's esophagus	0.000801	0.00168	CcSEcCtD
Sirolimus—Arthralgia—Omeprazole—Barrett's esophagus	0.000801	0.00168	CcSEcCtD
Sirolimus—Anxiety—Omeprazole—Barrett's esophagus	0.000798	0.00167	CcSEcCtD
Sirolimus—Anxiety—Esomeprazole—Barrett's esophagus	0.000798	0.00167	CcSEcCtD
Sirolimus—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.000795	0.00167	CcSEcCtD
Sirolimus—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.000795	0.00167	CcSEcCtD
Sirolimus—Discomfort—Esomeprazole—Barrett's esophagus	0.000791	0.00166	CcSEcCtD
Sirolimus—Discomfort—Omeprazole—Barrett's esophagus	0.000791	0.00166	CcSEcCtD
Sirolimus—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000788	0.0082	CbGpPWpGaD
Sirolimus—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000788	0.0082	CbGpPWpGaD
Sirolimus—FGF2—Angiopoietin receptor Tie2-mediated signaling—RELA—Barrett's esophagus	0.000783	0.00815	CbGpPWpGaD
Sirolimus—Confusional state—Esomeprazole—Barrett's esophagus	0.000774	0.00162	CcSEcCtD
Sirolimus—Confusional state—Omeprazole—Barrett's esophagus	0.000774	0.00162	CcSEcCtD
Sirolimus—EIF4E—BDNF signaling pathway—APC—Barrett's esophagus	0.000773	0.00805	CbGpPWpGaD
Sirolimus—EIF4E—Metabolism of proteins—CDX2—Barrett's esophagus	0.000768	0.00799	CbGpPWpGaD
Sirolimus—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.000767	0.00161	CcSEcCtD
Sirolimus—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.000767	0.00161	CcSEcCtD
Sirolimus—Infection—Omeprazole—Barrett's esophagus	0.000762	0.0016	CcSEcCtD
Sirolimus—Infection—Esomeprazole—Barrett's esophagus	0.000762	0.0016	CcSEcCtD
Sirolimus—Shock—Omeprazole—Barrett's esophagus	0.000755	0.00158	CcSEcCtD
Sirolimus—Shock—Esomeprazole—Barrett's esophagus	0.000755	0.00158	CcSEcCtD
Sirolimus—Nervous system disorder—Omeprazole—Barrett's esophagus	0.000753	0.00158	CcSEcCtD
Sirolimus—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.000753	0.00158	CcSEcCtD
Sirolimus—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.000751	0.00157	CcSEcCtD
Sirolimus—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.000751	0.00157	CcSEcCtD
Sirolimus—Tachycardia—Omeprazole—Barrett's esophagus	0.000749	0.00157	CcSEcCtD
Sirolimus—Tachycardia—Esomeprazole—Barrett's esophagus	0.000749	0.00157	CcSEcCtD
Sirolimus—Skin disorder—Omeprazole—Barrett's esophagus	0.000745	0.00156	CcSEcCtD
Sirolimus—Skin disorder—Esomeprazole—Barrett's esophagus	0.000745	0.00156	CcSEcCtD
Sirolimus—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.000742	0.00155	CcSEcCtD
Sirolimus—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.000742	0.00155	CcSEcCtD
Sirolimus—MTOR—IL2 signaling events mediated by PI3K—RELA—Barrett's esophagus	0.000739	0.0077	CbGpPWpGaD
Sirolimus—Anorexia—Omeprazole—Barrett's esophagus	0.000732	0.00153	CcSEcCtD
Sirolimus—Anorexia—Esomeprazole—Barrett's esophagus	0.000732	0.00153	CcSEcCtD
Sirolimus—MTOR—Wnt Signaling Pathway Netpath—APC—Barrett's esophagus	0.000721	0.0075	CbGpPWpGaD
Sirolimus—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.000699	0.00146	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.000699	0.00146	CcSEcCtD
Sirolimus—MTOR—Wnt Signaling Pathway Netpath—PPARG—Barrett's esophagus	0.000696	0.00724	CbGpPWpGaD
Sirolimus—Insomnia—Esomeprazole—Barrett's esophagus	0.000694	0.00145	CcSEcCtD
Sirolimus—Insomnia—Omeprazole—Barrett's esophagus	0.000694	0.00145	CcSEcCtD
Sirolimus—Paraesthesia—Esomeprazole—Barrett's esophagus	0.000689	0.00144	CcSEcCtD
Sirolimus—Paraesthesia—Omeprazole—Barrett's esophagus	0.000689	0.00144	CcSEcCtD
Sirolimus—MTOR—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HGF—Barrett's esophagus	0.000688	0.00716	CbGpPWpGaD
Sirolimus—Dyspnoea—Esomeprazole—Barrett's esophagus	0.000684	0.00143	CcSEcCtD
Sirolimus—Dyspnoea—Omeprazole—Barrett's esophagus	0.000684	0.00143	CcSEcCtD
Sirolimus—Somnolence—Esomeprazole—Barrett's esophagus	0.000682	0.00143	CcSEcCtD
Sirolimus—Somnolence—Omeprazole—Barrett's esophagus	0.000682	0.00143	CcSEcCtD
Sirolimus—Dyspepsia—Omeprazole—Barrett's esophagus	0.000676	0.00142	CcSEcCtD
Sirolimus—Dyspepsia—Esomeprazole—Barrett's esophagus	0.000676	0.00142	CcSEcCtD
Sirolimus—Decreased appetite—Omeprazole—Barrett's esophagus	0.000667	0.0014	CcSEcCtD
Sirolimus—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000667	0.0014	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.000663	0.00139	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.000663	0.00139	CcSEcCtD
Sirolimus—Constipation—Omeprazole—Barrett's esophagus	0.000656	0.00137	CcSEcCtD
Sirolimus—Pain—Esomeprazole—Barrett's esophagus	0.000656	0.00137	CcSEcCtD
Sirolimus—Constipation—Esomeprazole—Barrett's esophagus	0.000656	0.00137	CcSEcCtD
Sirolimus—Pain—Omeprazole—Barrett's esophagus	0.000656	0.00137	CcSEcCtD
Sirolimus—CYP3A7—Biological oxidations—CYP26A1—Barrett's esophagus	0.000641	0.00667	CbGpPWpGaD
Sirolimus—Feeling abnormal—Omeprazole—Barrett's esophagus	0.000632	0.00132	CcSEcCtD
Sirolimus—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.000632	0.00132	CcSEcCtD
Sirolimus—CYP3A7—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000632	0.00658	CbGpPWpGaD
Sirolimus—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000628	0.00131	CcSEcCtD
Sirolimus—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000628	0.00131	CcSEcCtD
Sirolimus—EIF4E—Cytokine Signaling in Immune system—HGF—Barrett's esophagus	0.000612	0.00637	CbGpPWpGaD
Sirolimus—MTOR—TSLP Signaling Pathway—RELA—Barrett's esophagus	0.000611	0.00636	CbGpPWpGaD
Sirolimus—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000607	0.00127	CcSEcCtD
Sirolimus—Abdominal pain—Omeprazole—Barrett's esophagus	0.000607	0.00127	CcSEcCtD
Sirolimus—Body temperature increased—Omeprazole—Barrett's esophagus	0.000607	0.00127	CcSEcCtD
Sirolimus—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000607	0.00127	CcSEcCtD
Sirolimus—EIF4E—BDNF signaling pathway—RELA—Barrett's esophagus	0.000604	0.00629	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—BMP4—Barrett's esophagus	0.000588	0.00613	CbGpPWpGaD
Sirolimus—MTOR—TSLP Signaling Pathway—CXCL8—Barrett's esophagus	0.000575	0.00599	CbGpPWpGaD
Sirolimus—MTOR—CDC42 signaling events—APC—Barrett's esophagus	0.000568	0.00591	CbGpPWpGaD
Sirolimus—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000565	0.00118	CcSEcCtD
Sirolimus—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000565	0.00118	CcSEcCtD
Sirolimus—EIF4E—Validated targets of C-MYC transcriptional activation—TP53—Barrett's esophagus	0.000565	0.00588	CbGpPWpGaD
Sirolimus—MTOR—SREBP signalling—PPARG—Barrett's esophagus	0.000555	0.00577	CbGpPWpGaD
Sirolimus—Asthenia—Esomeprazole—Barrett's esophagus	0.000551	0.00115	CcSEcCtD
Sirolimus—Asthenia—Omeprazole—Barrett's esophagus	0.000551	0.00115	CcSEcCtD
Sirolimus—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000546	0.00568	CbGpPWpGaD
Sirolimus—Pruritus—Esomeprazole—Barrett's esophagus	0.000543	0.00114	CcSEcCtD
Sirolimus—Pruritus—Omeprazole—Barrett's esophagus	0.000543	0.00114	CcSEcCtD
Sirolimus—MTOR—RANKL/RANK Signaling Pathway—RELA—Barrett's esophagus	0.000538	0.0056	CbGpPWpGaD
Sirolimus—Diarrhoea—Omeprazole—Barrett's esophagus	0.000525	0.0011	CcSEcCtD
Sirolimus—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000525	0.0011	CcSEcCtD
Sirolimus—SLC47A1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000514	0.00535	CbGpPWpGaD
Sirolimus—MTOR—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—APC—Barrett's esophagus	0.000511	0.00532	CbGpPWpGaD
Sirolimus—Dizziness—Esomeprazole—Barrett's esophagus	0.000508	0.00106	CcSEcCtD
Sirolimus—Dizziness—Omeprazole—Barrett's esophagus	0.000508	0.00106	CcSEcCtD
Sirolimus—FKBP1A—Spinal Cord Injury—PTGS2—Barrett's esophagus	0.000505	0.00526	CbGpPWpGaD
Sirolimus—MTOR—IL12-mediated signaling events—RELA—Barrett's esophagus	0.000502	0.00523	CbGpPWpGaD
Sirolimus—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.0005	0.0052	CbGpPWpGaD
Sirolimus—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000493	0.00514	CbGpPWpGaD
Sirolimus—FKBP1A—Spinal Cord Injury—CXCL8—Barrett's esophagus	0.00049	0.0051	CbGpPWpGaD
Sirolimus—Vomiting—Omeprazole—Barrett's esophagus	0.000488	0.00102	CcSEcCtD
Sirolimus—Vomiting—Esomeprazole—Barrett's esophagus	0.000488	0.00102	CcSEcCtD
Sirolimus—Rash—Esomeprazole—Barrett's esophagus	0.000484	0.00101	CcSEcCtD
Sirolimus—Rash—Omeprazole—Barrett's esophagus	0.000484	0.00101	CcSEcCtD
Sirolimus—Dermatitis—Esomeprazole—Barrett's esophagus	0.000483	0.00101	CcSEcCtD
Sirolimus—Dermatitis—Omeprazole—Barrett's esophagus	0.000483	0.00101	CcSEcCtD
Sirolimus—Headache—Omeprazole—Barrett's esophagus	0.000481	0.00101	CcSEcCtD
Sirolimus—Headache—Esomeprazole—Barrett's esophagus	0.000481	0.00101	CcSEcCtD
Sirolimus—MTOR—Oncostatin M Signaling Pathway—RELA—Barrett's esophagus	0.000471	0.0049	CbGpPWpGaD
Sirolimus—CYP3A5—Biological oxidations—CYP26A1—Barrett's esophagus	0.000463	0.00482	CbGpPWpGaD
Sirolimus—CYP3A5—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000457	0.00475	CbGpPWpGaD
Sirolimus—Nausea—Esomeprazole—Barrett's esophagus	0.000456	0.000955	CcSEcCtD
Sirolimus—Nausea—Omeprazole—Barrett's esophagus	0.000456	0.000955	CcSEcCtD
Sirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000453	0.00471	CbGpPWpGaD
Sirolimus—EIF4E—Gene Expression—NR1I2—Barrett's esophagus	0.000433	0.00451	CbGpPWpGaD
Sirolimus—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000421	0.00438	CbGpPWpGaD
Sirolimus—MTOR—Leptin signaling pathway—RELA—Barrett's esophagus	0.00042	0.00437	CbGpPWpGaD
Sirolimus—FGF2—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.000418	0.00435	CbGpPWpGaD
Sirolimus—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000405	0.00422	CbGpPWpGaD
Sirolimus—MTOR—LKB1 signaling events—TP53—Barrett's esophagus	0.000379	0.00395	CbGpPWpGaD
Sirolimus—SLCO1B1—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	0.000362	0.00376	CbGpPWpGaD
Sirolimus—EIF4E—Cytokine Signaling in Immune system—RELA—Barrett's esophagus	0.000355	0.0037	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000354	0.00368	CbGpPWpGaD
Sirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000344	0.00358	CbGpPWpGaD
Sirolimus—FGF2—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000343	0.00357	CbGpPWpGaD
Sirolimus—MTOR—Senescence and Autophagy in Cancer—CDKN2A—Barrett's esophagus	0.000334	0.00347	CbGpPWpGaD
Sirolimus—MTOR—BDNF signaling pathway—APC—Barrett's esophagus	0.000319	0.00332	CbGpPWpGaD
Sirolimus—MTOR—ErbB Signaling Pathway—TP53—Barrett's esophagus	0.000316	0.00329	CbGpPWpGaD
Sirolimus—MTOR—Senescence and Autophagy in Cancer—CXCL8—Barrett's esophagus	0.000302	0.00315	CbGpPWpGaD
Sirolimus—FKBP1A—Spinal Cord Injury—TP53—Barrett's esophagus	0.000301	0.00313	CbGpPWpGaD
Sirolimus—SLCO1B1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.0003	0.00312	CbGpPWpGaD
Sirolimus—FGF2—Downstream signaling events of B Cell Receptor (BCR)—RELA—Barrett's esophagus	0.000298	0.00311	CbGpPWpGaD
Sirolimus—FGF2—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	0.000285	0.00296	CbGpPWpGaD
Sirolimus—MTOR—Oncostatin M Signaling Pathway—TP53—Barrett's esophagus	0.000272	0.00284	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—GAST—Barrett's esophagus	0.000265	0.00275	CbGpPWpGaD
Sirolimus—FGF2—B Cell Activation—RELA—Barrett's esophagus	0.000264	0.00274	CbGpPWpGaD
Sirolimus—FGF2—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.00026	0.00271	CbGpPWpGaD
Sirolimus—MTOR—AMPK Signaling—TP53—Barrett's esophagus	0.00026	0.0027	CbGpPWpGaD
Sirolimus—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000259	0.0027	CbGpPWpGaD
Sirolimus—MTOR—BDNF signaling pathway—RELA—Barrett's esophagus	0.000249	0.0026	CbGpPWpGaD
Sirolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—RELA—Barrett's esophagus	0.000221	0.0023	CbGpPWpGaD
Sirolimus—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	0.000215	0.00224	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—SLC9A1—Barrett's esophagus	0.000212	0.00221	CbGpPWpGaD
Sirolimus—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000212	0.00221	CbGpPWpGaD
Sirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	0.000211	0.0022	CbGpPWpGaD
Sirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	0.000204	0.00213	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—HGF—Barrett's esophagus	0.0002	0.00208	CbGpPWpGaD
Sirolimus—MTOR—B Cell Activation—RELA—Barrett's esophagus	0.000196	0.00204	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—GAST—Barrett's esophagus	0.000194	0.00202	CbGpPWpGaD
Sirolimus—FGF2—Signaling by NGF—RELA—Barrett's esophagus	0.000194	0.00202	CbGpPWpGaD
Sirolimus—MTOR—Senescence and Autophagy in Cancer—TP53—Barrett's esophagus	0.000186	0.00193	CbGpPWpGaD
Sirolimus—SLCO1B1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000184	0.00191	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—SST—Barrett's esophagus	0.000181	0.00189	CbGpPWpGaD
Sirolimus—EIF4E—Metabolism of proteins—CXCL8—Barrett's esophagus	0.000164	0.00171	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	0.000163	0.0017	CbGpPWpGaD
Sirolimus—FGF2—Disease—SLC9A1—Barrett's esophagus	0.000161	0.00168	CbGpPWpGaD
Sirolimus—MTOR—Cellular responses to stress—CDKN2A—Barrett's esophagus	0.00016	0.00166	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—PTGES—Barrett's esophagus	0.000158	0.00164	CbGpPWpGaD
Sirolimus—FGF2—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	0.000155	0.00161	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—PPARG—Barrett's esophagus	0.000155	0.00161	CbGpPWpGaD
Sirolimus—MTOR—Cellular responses to stress—RELA—Barrett's esophagus	0.000153	0.0016	CbGpPWpGaD
Sirolimus—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.00015	0.00156	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—GAST—Barrett's esophagus	0.000147	0.00153	CbGpPWpGaD
Sirolimus—MTOR—Cellular responses to stress—CXCL8—Barrett's esophagus	0.000145	0.00151	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—PTGES—Barrett's esophagus	0.000145	0.00151	CbGpPWpGaD
Sirolimus—MTOR—Signaling by NGF—RELA—Barrett's esophagus	0.000144	0.0015	CbGpPWpGaD
Sirolimus—EIF4E—Gene Expression—PPARG—Barrett's esophagus	0.000142	0.00148	CbGpPWpGaD
Sirolimus—MTOR—Integrated Breast Cancer Pathway—TP53—Barrett's esophagus	0.000139	0.00144	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—SST—Barrett's esophagus	0.000133	0.00138	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—RELA—Barrett's esophagus	0.000125	0.0013	CbGpPWpGaD
Sirolimus—MTOR—Disease—SLC9A1—Barrett's esophagus	0.000119	0.00124	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—CYP26A1—Barrett's esophagus	0.000119	0.00124	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—RELA—Barrett's esophagus	0.000116	0.00121	CbGpPWpGaD
Sirolimus—FGF2—Immune System—HGF—Barrett's esophagus	0.000111	0.00116	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—RELA—Barrett's esophagus	0.000111	0.00115	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.00011	0.00114	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—CYP26A1—Barrett's esophagus	0.00011	0.00114	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—GAST—Barrett's esophagus	0.000109	0.00114	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—RELA—Barrett's esophagus	0.000106	0.00111	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—PTGES—Barrett's esophagus	0.000105	0.00109	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—SST—Barrett's esophagus	0.000101	0.00105	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—APC—Barrett's esophagus	0.0001	0.00105	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—APC—Barrett's esophagus	9.59e-05	0.000999	CbGpPWpGaD
Sirolimus—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	9.2e-05	0.000958	CbGpPWpGaD
Sirolimus—MTOR—Cellular responses to stress—TP53—Barrett's esophagus	8.88e-05	0.000924	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	8.82e-05	0.000918	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—SLC9A1—Barrett's esophagus	8.61e-05	0.000896	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	8.32e-05	0.000866	CbGpPWpGaD
Sirolimus—MTOR—Immune System—HGF—Barrett's esophagus	8.24e-05	0.000858	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—RELA—Barrett's esophagus	8.21e-05	0.000855	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—CYP26A1—Barrett's esophagus	7.92e-05	0.000824	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—SLC9A1—Barrett's esophagus	7.9e-05	0.000822	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PTGES—Barrett's esophagus	7.89e-05	0.000821	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—RELA—Barrett's esophagus	7.89e-05	0.000821	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—PTGS2—Barrett's esophagus	7.63e-05	0.000794	CbGpPWpGaD
Sirolimus—FGF2—Disease—APC—Barrett's esophagus	7.62e-05	0.000793	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—RELA—Barrett's esophagus	7.5e-05	0.00078	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—SST—Barrett's esophagus	7.48e-05	0.000779	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—CXCL8—Barrett's esophagus	7.06e-05	0.000735	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—APC—Barrett's esophagus	7.04e-05	0.000733	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	6.94e-05	0.000722	CbGpPWpGaD
Sirolimus—FGF2—Immune System—RELA—Barrett's esophagus	6.44e-05	0.000671	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	5.98e-05	0.000622	CbGpPWpGaD
Sirolimus—FGF2—Disease—PTGS2—Barrett's esophagus	5.78e-05	0.000602	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—SLC9A1—Barrett's esophagus	5.71e-05	0.000594	CbGpPWpGaD
Sirolimus—MTOR—Disease—APC—Barrett's esophagus	5.65e-05	0.000588	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—RELA—Barrett's esophagus	5.5e-05	0.000572	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—APC—Barrett's esophagus	5.33e-05	0.000555	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—CXCL8—Barrett's esophagus	5.18e-05	0.000539	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	4.95e-05	0.000515	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PTGES—Barrett's esophagus	4.86e-05	0.000506	CbGpPWpGaD
Sirolimus—MTOR—Immune System—RELA—Barrett's esophagus	4.78e-05	0.000498	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—TP53—Barrett's esophagus	4.34e-05	0.000451	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	4.31e-05	0.000448	CbGpPWpGaD
Sirolimus—MTOR—Disease—PTGS2—Barrett's esophagus	4.29e-05	0.000447	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—RELA—Barrett's esophagus	4.17e-05	0.000434	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—APC—Barrett's esophagus	3.96e-05	0.000412	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—PPARG—Barrett's esophagus	3.93e-05	0.000409	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CXCL8—Barrett's esophagus	3.93e-05	0.000409	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	3.68e-05	0.000383	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—PPARG—Barrett's esophagus	3.61e-05	0.000375	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—TP53—Barrett's esophagus	3.18e-05	0.000331	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—RELA—Barrett's esophagus	3.09e-05	0.000322	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—PTGS2—Barrett's esophagus	3.09e-05	0.000322	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CXCL8—Barrett's esophagus	2.91e-05	0.000303	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—PTGS2—Barrett's esophagus	2.84e-05	0.000295	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	2.65e-05	0.000276	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—PPARG—Barrett's esophagus	2.61e-05	0.000271	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—TP53—Barrett's esophagus	2.41e-05	0.000251	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—PTGS2—Barrett's esophagus	2.05e-05	0.000213	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PPARG—Barrett's esophagus	1.97e-05	0.000205	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—TP53—Barrett's esophagus	1.79e-05	0.000186	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PTGS2—Barrett's esophagus	1.55e-05	0.000161	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PPARG—Barrett's esophagus	1.21e-05	0.000126	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	9.53e-06	9.92e-05	CbGpPWpGaD
